Dr. Adriana Kiędzierska-Mencfeld, CEO of Rezon Bio, a Polpharma Biologics brand, was awarded the Woman of the Year title at the 2025 CPHI Pharma Awards at CPHI Frankfurt.

The Woman of the Year category honors leaders who combine scientific excellence, strategic business vision, and transformative leadership — shaping organizational culture and influencing the future direction of the biotechnology sector.

This recognition is not only a personal achievement for Dr. Kiędzierska-Mencfeld, but also a symbolic milestone for Rezon Bio, a company that, in recent years, has evolved from a research and development organization into a full-scale CDMO (Contract Development and Manufacturing Organization).

The award highlights the growing importance of the leadership values she represents — rooted in trust, collaboration, and human development. It signals a shift in the global biotech landscape, where innovation is defined not only by technological advancement, but also by the ability to build cultures of shared ownership and continuous learning.

“This nomination shows that the global biotech community values trust, shared knowledge, and providing people with the space to grow. In a client-focused CDMO environment, continuous improvement, solution-seeking, and collaboration are core to how we operate. We pursue ambitious business goals, but I will never allow them to overshadow the human perspective. True passion is what drives exceptional outcomes,” remarked Dr. Kiędzierska-Mencfeld.